InVivo Biosystems accelerates drug discovery for neurological, metabolic, and rare monogenic diseases through its premier proprietary platform, RapidGen™. By harnessing cutting-edge -omics data and multiplexed CRISPR technology, the RapidGen™ platform streamlines target identification and enables multimodal therapeutic screening with precision. With advanced in vivo wet lab capabilities, InVivo Biosystems delivers robust behavioral and molecular insights, driving innovation and fostering strategic partnerships to revolutionize preclinical research.
Company Details
- Employees
- 59
- Founded
- -
- Address
- 1505 Westec Dr, Eugene,oregon 97402,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- nemametrix.com
- Keywords
- Drug discovery, Human biology, Animal biology, Understanding human diseases, Disease modeling.
- HQ
- Eugene, Oregon
Invivo Biosystems Questions
Invivo Biosystems's website is nemametrix.com
Invivo Biosystems's LinkedIn profile is https://www.linkedin.com/company/invivobiosystems
Invivo Biosystems has
59 employees.
View email and phone details for 59
employees at Invivo Biosystems.
Invivo Biosystems's industry is
Biotechnology Research
Invivo Biosystems's top competitors are
Agonox, Inc.,
Twist Bioscience,
Araceli Biosciences,
Xbiologix,
Oregon Bioscience Association,
Sedia Biosciences Corp.,
Pdx Pharmaceuticals,
Bioreperia,
Aridica,
Invenesis.
Invivo Biosystems's categories are Biotechnology Research
Invivo Biosystems's founding year is 2011
